← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:588 | 588 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:588 | 588 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0400 | 72196-0400-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Valine; Phenylalanine; Tryptophan | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:588 | 588 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:588 | 588 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-114 | 70092-114-50 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:588 | 588 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0018 | 71139-0018-1 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:588 | 588 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Choline Chloride; Methionine; Cyanocobalamin | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:588 | 588 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-301 | 73702-301-15 | Ketamine | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:589 | 589 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-144 | 73702-144-60 | Nicotinamide Riboside Chloride 100 mg | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:589 | 589 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:589 | 589 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-996 | 69374-996-05 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:589 | 589 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:589 | 589 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 51754-9150 | 51754-9150-1 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:589 | 589 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-3 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:589 | 589 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:589 | 589 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-559 | 69374-559-30 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:589 | 589 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-16 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:589 | 589 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-023 | 71506-023-03 | Glycopyrrolate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:589 | 589 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0402 | 72196-0402-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Glycine; Phenylalanine; Tryptophan; Valine; Alanine | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:589 | 589 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:589 | 589 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-116 | 70092-116-75 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:589 | 589 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-234 | 68985-234-91 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:589 | 589 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Choline Chloride; Methionine; Cyanocobalamin | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:589 | 589 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9081 | 71266-9081-1 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:590 | 590 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-401 | 73693-401-01 | TESTOSTERONE 50MG | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:590 | 590 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:590 | 590 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:590 | 590 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:590 | 590 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 51754-9160 | 51754-9160-1 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:590 | 590 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-2 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:590 | 590 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:590 | 590 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-3 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:590 | 590 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-17 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:590 | 590 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-104 | 71449-104-11 | Glycopyrrolate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:590 | 590 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutamine | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:590 | 590 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-4 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:590 | 590 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1079 | 73013-1079-1 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:590 | 590 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:590 | 590 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Methionine; Choline Chloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:590 | 590 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-155 | 73177-155-27 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:591 | 591 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-073 | 70092-073-44 | Rocuronium PF 10 mg/ml 5ml syr | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:591 | 591 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-989 | 69374-989-05 | Diltiazem Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:591 | 591 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-530 | 69374-530-25 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:591 | 591 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:591 | 591 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-2107 | 62295-2107-2 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:591 | 591 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2082 | 71286-2082-1 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:591 | 591 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:591 | 591 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-2 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:591 | 591 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-30 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:591 | 591 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9015 | 71266-9015-5 | Glycopyrrolate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:591 | 591 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5101 | 26436-5101-3 | Glutamine | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:591 | 591 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-3 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:591 | 591 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:591 | 591 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:591 | 591 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Methionine; Choline Chloride; Cyanocobalamin | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:591 | 591 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6616 | 71300-6616-4 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:592 | 592 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-021 | 73198-021-05 | Phenylephrine | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:592 | 592 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6054 | 72196-6054-1 | Diltiazem Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:592 | 592 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:592 | 592 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:592 | 592 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-6030 | 71139-6030-1 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:592 | 592 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2082 | 71286-2082-2 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:592 | 592 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-01 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:592 | 592 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-1 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:592 | 592 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-05 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:592 | 592 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9015 | 71266-9015-3 | Glycopyrrolate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:592 | 592 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutamine | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:592 | 592 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:592 | 592 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:592 | 592 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:592 | 592 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Methionine; Choline Chloride; Methylcobalamin; Pyridoxine | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:592 | 592 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-154 | 73177-154-28 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:593 | 593 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-177 | 73198-177-10 | Niagen | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:593 | 593 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6055 | 72196-6055-1 | Diltiazem Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:593 | 593 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-525 | 69374-525-25 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:593 | 593 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:593 | 593 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-251 | 70004-251-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:593 | 593 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:593 | 593 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-05 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:593 | 593 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2013 | 71286-2013-1 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:593 | 593 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5035 | 71266-5035-1 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:593 | 593 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2004 | 71266-2004-9 | Glycopyrrolate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:593 | 593 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:593 | 593 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:593 | 593 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1044 | 73013-1044-1 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:593 | 593 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:593 | 593 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Pyridoxine Hydrochloride; Methionine; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Choline Chloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:593 | 593 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-154 | 73177-154-27 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:594 | 594 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-615 | 81375-615-01 | Moxifloxacin SI | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:594 | 594 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6054 | 71285-6054-1 | Diltiazem Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:594 | 594 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:594 | 594 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-264 | 70004-264-22 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:594 | 594 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-22 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:594 | 594 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:594 | 594 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-03 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:594 | 594 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2013 | 71286-2013-2 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:594 | 594 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-546 | 70092-546-35 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:594 | 594 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2004 | 71266-2004-8 | Glycopyrrolate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:594 | 594 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:594 | 594 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-01 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:594 | 594 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1030 | 73013-1030-1 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:594 | 594 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:594 | 594 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Pyridoxine Hydrochloride; Methionine; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Choline Chloride; Levocarnitine | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:594 | 594 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-27 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:595 | 595 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-145 | 82396-145-13 | Lorazepam | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:595 | 595 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6055 | 71285-6055-1 | Diltiazem Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:595 | 595 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:595 | 595 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-526 | 69374-526-20 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:595 | 595 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:595 | 595 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:595 | 595 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:595 | 595 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2011 | 71286-2011-1 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:595 | 595 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-113 | 70092-113-79 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:595 | 595 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-109 | 73702-109-32 | Glycopyrrolate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:595 | 595 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 67157-135 | 67157-135-30 | Glutathione | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:595 | 595 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-30 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:595 | 595 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-4 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:595 | 595 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9115 | 71266-9115-1 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:595 | 595 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Pyridoxine Hydrochloride; Methionine; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Choline Chloride; Levocarnitine | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:595 | 595 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-02 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:596 | 596 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6647 | 71300-6647-9 | NALTREXONE HYDROCHLORIDE | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:596 | 596 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:596 | 596 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:596 | 596 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-4272 | 60652-4272-1 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:596 | 596 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-289 | 70004-289-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:596 | 596 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:596 | 596 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:596 | 596 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2012 | 71286-2012-1 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:596 | 596 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-293 | 70092-293-49 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:596 | 596 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-109 | 73702-109-15 | Glycopyrrolate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:596 | 596 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5028 | 26436-5028-3 | Glutathione | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:596 | 596 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-03 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:596 | 596 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-3 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:596 | 596 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5055 | 71266-5055-2 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:596 | 596 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6487 | 71266-6487-5 | Iohexol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:596 | 596 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-35 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:597 | 597 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4607 | 72934-4607-8 | Honista | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:597 | 597 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:597 | 597 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:597 | 597 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:597 | 597 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-32 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:597 | 597 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:597 | 597 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:597 | 597 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-286 | 70092-286-74 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:597 | 597 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-16 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:597 | 597 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-125 | 63037-125-25 | Glycopyrrolate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:597 | 597 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2403 | 72627-2403-1 | Glutathione | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:597 | 597 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-05 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:597 | 597 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1042 | 73013-1042-1 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:597 | 597 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6505 | 72934-6505-2 | Hydroquinone | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:597 | 597 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6488 | 71266-6488-3 | Iohexol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:597 | 597 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-069 | 71449-069-11 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:598 | 598 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-4002 | 73013-4002-2 | Ropivacaine HCl | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:598 | 598 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:598 | 598 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:598 | 598 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:598 | 598 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-244 | 70004-244-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:598 | 598 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:598 | 598 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:598 | 598 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-03 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:598 | 598 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:598 | 598 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6084 | 72196-6084-1 | Glycopyrrolate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:598 | 598 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2402 | 72627-2402-1 | Glutathione | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:598 | 598 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1030 | 73013-1030-1 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:598 | 598 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1045 | 73013-1045-1 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:598 | 598 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6513 | 72934-6513-2 | Hydroquinone | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:598 | 598 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0413 | 71285-0413-1 | Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Dextrose Monohydrate; Histidine; Arginine; Taurine; Leucine; Methionine; Proline; Aspartic Acid | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:598 | 598 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-069 | 71449-069-32 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:599 | 599 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1040 | 73013-1040-1 | Hydromorphone HCl | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:599 | 599 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:599 | 599 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:599 | 599 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:599 | 599 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-530 | 69374-530-25 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:599 | 599 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:599 | 599 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:599 | 599 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-16 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:599 | 599 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-22 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:599 | 599 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-638 | 70004-638-09 | Glycopyrrolate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:599 | 599 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:599 | 599 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1042 | 73013-1042-1 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:599 | 599 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1040 | 73013-1040-1 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:599 | 599 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6517 | 72934-6517-2 | Hydroquinone | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:599 | 599 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 80098-030 | 80098-030-90 | Isosulfan Blue | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:599 | 599 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-3 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:600 | 600 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-177 | 73198-177-05 | Niagen | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:600 | 600 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dimethicone | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:600 | 600 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-289 | 70004-289-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:600 | 600 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fludrocortisone Acetate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:600 | 600 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-253 | 70004-253-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:600 | 600 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:600 | 600 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:600 | 600 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-01 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:600 | 600 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-55 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:600 | 600 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:600 | 600 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:600 | 600 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1045 | 73013-1045-1 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:600 | 600 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:600 | 600 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6524 | 72934-6524-2 | Hydroquinone | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:600 | 600 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1531 | 72934-1531-2 | Ivermectin; Metronidazole | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:600 | 600 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-4 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:601 | 601 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-060 | 71506-060-58 | Epinephrine | 2025-1 | valid | 0 | 2026-09-18 |